2,661 results on '"Witte, T."'
Search Results
102. Methodisch werken: de fiets van het sociaal werk
103. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
104. Sekundäre Immundefizienz bei rheumatologischen Erkrankungen
105. Pathogenetic role of glomerular CXCL13 expression in lupus nephritis
106. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden
107. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT
108. Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
109. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia
110. Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab: Was ist aus immunologischer Sicht sinnvoll?
111. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings
112. Ganzkörperhyperthermie in der Schmerztherapie: Eine kontrollierte Studie an Patienten mit Fibromyalgiesyndrom
113. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation
114. AB0255 BASELINE CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB IN GERMAN REAL-WORLD PRACTICE: RESULTS FROM THE POST-MARKETING OBSERVATIONAL UPwArds STUDY
115. OP0019 DEFINING SYSTEMIC LUPUS ERYTHEMATOSUS MOLECULAR TAXONOMY THROUGH DATA-DRIVEN RESTRATIFICATION AND IDENTIFICATION OF CLUSTER-TAILORED DRUGS FOR A PERSONALIZED MEDICINE APPROACH
116. OP0260-HPR PREDICTORS OF WORK PARTICIPATION IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER 12 MONTHS OF T2T THERAPY INTERVENTION
117. AB0707 RHEUMATOLOGY PATIENT CARE IN THE COVID-19 PANDEMIC: TELEMEDICINE, DELEGATION, PATIENT SATISFACTION AND VACCINATION BEHAVIOUR
118. AB0322 ASSOCIATION OF DEPRESSIVE SYMPTOMS ASSESSED BY BDI II WITH PHYSICAL ACTIVITY IN PATIENTS WITH PRIMARY SJÖGREN´S SYNDROME
119. Diagnostischer Mehrwert der 18F-FDG PET/CT bei Abklärung einer steroid-refraktären Großgefäßvaskulitis und Polymyalgia rheumatica
120. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
121. The EBMT activity survey: 1990–2010
122. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis
123. Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
124. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene
125. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
126. [S2k guidelines: management of large-vessel vasculitis]
127. Female-Versus-Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation
128. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
129. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry
130. Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
131. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
132. Pathogenese und Diagnostik des Sjögren-Syndroms
133. Influence of the IL17A locus in giant cell arteritis susceptibility
134. Autoantibodies against CD74 in spondyloarthritis
135. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis
136. Eosinophile Fasziitis und Asplenie
137. Association of UCP2 −866 G/A polymorphism with chronic inflammatory diseases
138. Temporohyoid osteoarthropathy in the horse
139. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS FEASIBLE AFTER SOLID ORGAN TRANSPLANTATION: FINAL ANALYSIS BY THE EARLY COMPLICATIONS SUBCOMMITTEE OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY, EBMT: PH-P351
140. THE REVISED IPSS (IPSS-R) AT TRANSPLANT PREDICTS OVERALL AND RELAPSE-FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN MDS/SAML: A RETROSPECTIVE ANALYSIS OF THE EBMT CHRONIC MALIGNANCIES WORKING PARTY: WP-O014
141. REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA: A COMPARISON OF TANDEM AUTO-ALLOGRAFT TO EARLY REDUCED INTENSITY ALLOGRAFT AS UPFRONT TRANSPLANT: AN EBMT ANALYSIS ON BEHALF OF THE PLASMA CELL DISORDERS: PH-O144
142. IMPACT OF CYTOGENETIC USING THE IPSS REVISED CYTOGENETIC CLASSIFICATION ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MDS OR AML EVOLVING FROM MDS: A RETROSPECTIVE MULTICENTER STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT: PH-O012
143. The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains
144. Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus
145. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
146. Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients
147. Association of common variable immunodeficiency with vitamin B6 deficiency
148. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
149. Three horses with bilateral sinonasal progressive haematomas not associated with the ethmoidal labyrinth
150. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.